24
Participants
Start Date
April 30, 2008
Primary Completion Date
December 2, 2013
Study Completion Date
December 2, 2013
Lanreotide 90 mg slow release formulation
Lanreotide 90 mg slow release formulation is injected deep subcutaneously, every 4 weeks, three times and compared to placebo
Placebo
Placebo for somatuline slow release 90 mg
University Hospitals Leuven, Leuven
ZOL Genk, Genk
AZ St. Lucas, Brugges
Collaborators (1)
Ipsen
INDUSTRY
Universitaire Ziekenhuizen KU Leuven
OTHER